D.E. Shaw & Co’s CureVac CVAC Stock Holding History

D.E. Shaw & Co’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,000	Closed	-$588K	–	5403
2022 Q1	$588K	Hold	30,000	–	–	﹤0.01%	4272
2021 Q4	$1.03M	Hold	30,000	–	–	﹤0.01%	3910
2021 Q3	$1.64M	Hold	30,000	–	–	﹤0.01%	3204
2021 Q2	$2.2M	Buy	+30,000	New	+$3M	﹤0.01%	2848

D.E. Shaw & Co's CVAC Position: Q1 2026 in Review

D.E. Shaw & Co sold out of CureVac (CVAC) in Q1 2026, closing a stake of 124,432 shares — an estimated $562K sold.

D.E. Shaw & Co first reported a position in CVAC in Q4 2020 and held it in 14 quarters. The position peaked at $6.76M in Q4 2020. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

D.E. Shaw & Co reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
D.E. Shaw & Co sold 124,432 CureVac shares in Q1 2026, an estimated $562K.
D.E. Shaw & Co first reported a position in CureVac in Q4 2020 and held it in 14 quarters.
D.E. Shaw & Co's CureVac position peaked at $6.76M in Q4 2020.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.